PTJ
MXCT icon

Paul Tudor Jones’s MaxCyte MXCT Stock Holding History

Paul Tudor Jones’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.3K Buy
+78,313
New +$78K ﹤0.01% 3413
2021
Q4 		– Sell
-25,512
Closed -$312K – 2807
2021
Q3 		$312K Buy
+25,512
New +$385K 0.01% 2007

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Paul Tudor Jones's MXCT Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in MaxCyte (MXCT) in Q2 2026: 78,313 shares worth $96.3K. The stake represents ﹤0.01% of the portfolio and ranks #3413 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in MXCT as recently as Q3 2021.

Paul Tudor Jones first reported a position in MXCT in Q3 2021 and has held it in 2 quarters since. The position peaked at $312K in Q3 2021. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Paul Tudor Jones held 78,313 shares of MaxCyte worth $96.3K as of Q2 2026.
  • MaxCyte was a new Paul Tudor Jones position in Q2 2026.
  • MaxCyte made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #3413 holding.
  • Paul Tudor Jones first reported a position in MaxCyte in Q3 2021 and has held it in 2 quarters since.
  • Paul Tudor Jones's MaxCyte position peaked at $312K in Q3 2021.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.